首页|熊去氧胆酸生物合成优化策略及应用

熊去氧胆酸生物合成优化策略及应用

扫码查看
熊去氧胆酸(ursodeoxycholic acid,UDCA)是一种内源性胆汁酸,是多种肝脏疾病的治疗药物及抗癌药物。UDCA的化学合成,存在反应过程复杂、环境不友好、产率低等问题,而生物合成相对绿色,高效,安全,已然成为研究和工业化生产的热点。UDCA的生物合成是以廉价的鹅去氧胆酸(cheap chenodeoxycholic acid,CDCA)、胆酸(cholic acid,CA)或石胆酸(lithocholic acid,LCA)作为底物,通过游离酶催化或者全细胞合成,其中以CDCA为底物应用最为广泛。游离酶催化的一锅一步法或一锅两步法采用羟基类固醇脱氢酶(HSDHs);全细胞合成则是使用表达相关HSDHs的工程菌株或具有C-7羟基化活性的P450单加氧酶的工程菌株。尽管UDCA生物合成产率较高,但也在工业化生产上仍具有一定的局限性,包括酶活、稳定性、关键酶的表达条件和催化体系以及微生物致病性等。因此,优化熊去氧胆酸合成策略非常重要。本文综述了近年来通过蛋白质工程技术对关键酶进行改造、挖掘和修饰辅因子特异性HSDHs、辅因子再生、固定化酶技术以及工程化菌株等策略优化UDCA合成,分析了不同策略的优势与不足,并对实现UDCA生物合成工业化发展方向进行了展望。
Optimization strategy and application of ursodeoxycholic acid biosynthesis
Ursodeoxycholic acid(UDCA)is an endogenous bile acid,which is a therapeutic and anticancer drug for a va-riety of liver diseases.The chemical synthesis of UDCA have many problems,such as complex reaction process,environ-mentally unfriendly,low yield and so on.But the green,efficient and safe biosynthesis has become the focus of research and industrial production.UDCA biosynthesis is based on cheap chenodeoxycholic acid(CDCA),cholic acid(CA)or lithocholic acid(LCA)as substrates,through free enzyme catalysis or whole cell synthesis,in which CDCA is the most widely used substrate.Free enzyme catalyzed one pot,one-step/two-step method using hydroxysteroid dehydrogenase(HSDHs);Whole cell synthesis is using engineering strains expressing hsdhs or P450 monooxygenase with C-7 hydroxyl-ation activity.Although the yield of UDCA biosynthesis is high,it still has some limitations in industrial production,inclu-ding enzyme activity,stability,expression conditions and catalytic system of key enzymes,and microbial pathogenicity.Therefore,it is very important to optimize the synthesis strategy of ursodeoxycholic acid.In this review,the strategies for optimizing ursodeoxycholic acid biosynthesis in recent years,such as the modification of key enzymes by protein engineer-ing technology,the mining and modification of cofactor specific hsdhs,cofactor regeneration,immobilized enzyme technol-ogy and engineering strains,were reviewed.The advantages and disadvantages of different strategies were analyzed,and the development direction of industrialization of ursodeoxycholic acid biosynthesis was prospected.

Ursodeoxycholic acidBiosynthesisFree-enzyme catalysisWhole-cell synthesis

周奕帆、孙敬方

展开 >

中国药科大学基础医学与临床药学学院,南京 210009

熊去氧胆酸 生物合成 游离酶催化 全细胞合成

国家重点研发计划

2019YFA090402

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(15)